Abstract:Objectives: To estimate prevalence of selected diagnosed chronic diseases among patients attending general practice, in the general practice patient population, and in the Australian population, and to compare population estimates with those of the National Health Survey (NHS). Design, setting and participants: In late 2005, 305 general practitioners each provided data for about 30 consecutive patients (total, 9156) as part of the BEACH (Bettering the Evaluation And Care of Health) program, a continuous national study of general practice activity. GPs used their knowledge of the patient, patient self-report, and medical records as sources. Main outcome measures: Crude prevalence of each listed condition currently under management among surveyed patients, and adjusted prevalence for the general practice patient population, and the national population. Results: 39.6% of respondents had none of the listed conditions diagnosed; 30.0% had a cardiovascular problem (uncomplicated hypertension, 17.6%; ischaemic heart disease, 9.5%); 24.8% had a psychological problem (depression, 14.2%; anxiety, 10.7%); 22.8% had arthritis, mostly osteoarthritis (20.0%); 10.7% had asthma; and 8.3% had diabetes, mostly type 2 (7.2%). Adjustment to the population attending general practice resulted in lower estimates for cardiovascular disease, arthritis and diabetes but had little effect on prevalence of asthma and psychological problems. After adjusting for non-attenders, about one in five people in the population had a cardiovascular problem, a similar proportion had a psychological problem, 14.8% had arthritis, and about 10% had asthma, hyperlipidaemia and gastro-oesophageal reflux disease. Estimates were similar to NHS results for any arthritis, asthma, and malignant neoplasms; higher for any cardiovascular problem; far higher for specific cardiovascular diseases, cerebrovascular disease and hyperlipidaemia; and almost twice the NHS estimate for psychological problems (particularly depression and anxiety). Estimates for type 1 diabetes aligned with NHS results, but were far higher for "all diabetes" and type 2 diabetes. Conclusions: This study offers an alternative, perhaps more accurate, approach to measurement of disease prevalence than the NHS approach, which relies on respondent self-report alone. It provides valid prevalence estimates with the help of GPs at a fraction of the cost of the NHS. This study could be repeated annually to augment other data sources and better define existing health needs in the population.

Measuring the impact of rare diseases in Tasmania, Australia

Informing a national rare disease registry strategy in Australia: a mixed methods study

Survey of healthcare experiences of Australian adults living with rare diseases

Assessing the unmet needs of genomic testing in Australia: a geospatial exploration

Cluster analysis and visualisation of electronic health records data to identify undiagnosed patients with rare genetic diseases

Integrated multi-omics for rapid rare disease diagnosis on a national scale

Estimating prevalence of common chronic morbidities in Australia

Creating an interactive map visualising the geographic variations of the burden of diabetes to inform policymaking: An example from a cohort study in Tasmania, Australia

Measuring what counts in Aboriginal and Torres Strait Islander care: a review of general practice datasets available for assessing chronic disease care

Co-constructing effective collective intelligence networks in rare diseases: a mixed method approach to identify the parameters that matter for patients, professionals and policy-makers, piloted in Cyprus

Undercounting diagnoses in Australian general practice: a data quality study with implications for population health reporting

The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia

Establishing Patient Registries for Rare Diseases: Rationale and Challenges

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database

Rare diseases, spotlighting amyotrophic lateral sclerosis, Huntington’s disease, and myasthenia gravis: Insights from landscape analysis of current research

Use of State Administrative Data Sources to Study Adolescents and Young Adults with Rare Conditions

Advancing diagnosis and research for rare genetic diseases in Indigenous peoples

Rare diseases: Insights from landscape analysis of current research, spotlighting amyotrophic lateral sclerosis, Huntington’s disease, and myasthenia gravis

Synthetic datasets for open software development in rare disease research

Pareto-principle in rare disease education: assessing the representation of common rare diseases in medical education and coding systems

Epidemiological Research on Rare Diseases Using Large-Scale Online Search Queries and Reported Case Data.